Botulinum toxin A and neuropathic pain: An update
Toxicon. 2023 Jun 27:107208. doi: 10.1016/j.toxicon.2023.107208. Online ahead of print.ABSTRACTBotulinum toxin type A is a widely used neurotoxin for the treatment of muscle hyperactivity such as dystonia and spasticity. Several clinical trials have also reported an efficacy of subcutaneous or intradermal administrations of botulinum toxin A on various neuropathic pain conditions including idiopathic trigeminal neuralgia and found that specific sensory phenotypes were predictors of the response. This narrative review summarizes the potential mechanisms of action, efficacy and safety of botulinum toxin A in neuropathic pain...
Source: Toxicon - June 29, 2023 Category: Toxicology Authors: A Spagna N Attal Source Type: research
Botulinum toxin A and neuropathic pain: An update
Toxicon. 2023 Jun 27:107208. doi: 10.1016/j.toxicon.2023.107208. Online ahead of print.ABSTRACTBotulinum toxin type A is a widely used neurotoxin for the treatment of muscle hyperactivity such as dystonia and spasticity. Several clinical trials have also reported an efficacy of subcutaneous or intradermal administrations of botulinum toxin A on various neuropathic pain conditions including idiopathic trigeminal neuralgia and found that specific sensory phenotypes were predictors of the response. This narrative review summarizes the potential mechanisms of action, efficacy and safety of botulinum toxin A in neuropathic pain...
Source: Toxicon - June 29, 2023 Category: Toxicology Authors: A Spagna N Attal Source Type: research
Clinical use of botulinum toxin type A in pain medicine
This article provides an overview of the current clinically relevant areas of application of botulinum toxin in the field of pain medicine.PMID:37365293 | DOI:10.1007/s00482-023-00730-9 (Source: Schmerz)
Source: Schmerz - June 26, 2023 Category: Anesthesiology Authors: A Schwarzer T M äcken E K Enax-Krumova Source Type: research
Clinical use of botulinum toxin type A in pain medicine
This article provides an overview of the current clinically relevant areas of application of botulinum toxin in the field of pain medicine.PMID:37365293 | DOI:10.1007/s00482-023-00730-9 (Source: Schmerz)
Source: Schmerz - June 26, 2023 Category: Anesthesiology Authors: A Schwarzer T M äcken E K Enax-Krumova Source Type: research
A Study on Clinical Profile of Hemifacial Spasm in India and the Therapeutic Response to Botulinum Toxin Type A Injection as well as Pre and Postinjection Quality of Life
CONCLUSION: This is one of the largest studies on the effects of botulinum toxin in subjects with HFS in the Indian population. Periodic injection of botulinum toxin is a safe and effective therapy for subjects with HFS. There is a significant improvement in the quality of life following botulinum toxin therapy in subjects with HFS. Adverse effects were local, mild, well-tolerated, and reversible.PMID:37355970 | DOI:10.5005/japi-11001-0161 (Source: Journal of the Association of Physicians of India)
Source: Journal of the Association of Physicians of India - June 25, 2023 Category: General Medicine Authors: Amar Kumar Misra Joydeep Mukherjee Sanjay Kumar Gautam Guha Bijendra Mohanty Pideno S Ngullie Akash Manna Tapashya Nanda Amit Kumar Das Kamlesh Tiwari Source Type: research
